The Australian Early Psychosis Collaborative Consortium (AEPCC) is pleased to announce our inaugural forum will be held in Melbourne on Wednesday, 22 March 2023. If you are passionate about improving care and outcomes for young people experiencing early psychosis, we would love for you to join us.
A key aim of AEPCC’s Clinical Trials and Translation Network (CTTN) is to drive the collaborative development of large-scale and priority-driven clinical trials, in true partnership with all parts of the early psychosis community.
This all-day, in-person and interactive event will bring together the early psychosis sector from across Australia to connect, network and collectively plan the next generation of early psychosis clinical trials, so that we can develop and test new treatments for young people experiencing early psychosis. And we need you to help us do this!
Who should attend?
The AEPCC Forum 2023 is for early psychosis researchers, clinicians and lived-experience community members. We know from other areas of health, that the most successful clinical trials networks are those that are driven by the whole community, for the community.
How will the forum work?
In 2022 we asked the early psychosis community what were the most important questions about early psychosis that still need to be addressed. The AEPCC Forum 2023 will use these priorities to guide the development of emergent clinical trials on the day (don’t worry, we’ll share these priorities before the Forum as well as information about designing a clinical trial!).
AEPCC Forum 2023 attendees will work in multidisciplinary groups to design early psychosis clinical trials, which will be pitched to attendees and a feedback panel. We want these trials to ultimately lead to the development of funding applications to support the implementation of multi-site, national trials (e.g., funding applications to NHMRC, MRFF) later in 2023. This will be a particularly valuable opportunity for early career researchers, clinicians and lived experience community members who are new to clinical trials. You will have the option to remain involved in the trial if they are taken forward (for example as an investigator on the grant, a site for recruitment, or lived experience expert).
Keynote Speaker
AEPCC is delighted to welcome Professor Christopher Reid as our inaugural keynote speaker. Professor Reid is the John Curtin Distinguished Professor in the Curtin School of Population Health at Curtin University and is a cardiovascular epidemiologist and clinical trialist with a specific interest in large scale clinical trials, quality improvement and outcomes research. He holds a NHMRC Principal Research Fellowship and has had continual NHMRC research funding since 1997. He holds Professorial Research Fellow positions at both Curtin and Monash University and is Co-Director of the Monash Centre for Cardiovascular Research and Education in Therapeutics (CCRE) and Director of the Curtin Centre for Clinical Research and Education (CCRE). He is also a current Board Director of ACTA, the Australian Clinical Trials Alliance.
Forum Details
Date Wednesday, 22 March 2023
Time 9:00 am – 5:00 pm
Location The Events Centre, Collins Square, 727 Collins St, Melbourne
Program
8.30 am – 9.30 am Registration
9.30 am – 9.45 am Welcome, AEPCC updates and plans for 2023 and beyond
9.45 am – 10.15 am Keynote speaker, Professor Christopher Reid on The Power of Clinical Trial Networks and Clinical Quality Registries
10.15 am – 10.40 am Early Psychosis Research Priorities – update on national consultations
10.40 am – 11.00 am Morning tea break
11.00 am – 12.30 pm Design an early psychosis clinical trial!
Attendees will work in multidisciplinary and multi-experience groups to design a clinical trial based on the early psychosis research priorities that have been identified through our community consultations.
12.30 pm – 1.30 pm Lunch
1.30 pm – 2:10 pm First Pitch Session
2:10 pm – 3:10 pm Second clinical trial design session (same trials, different groups!)
3:10 pm – 3:30 pm Afternoon tea break
3:30 pm – 4:30 pm Second Pitch and Feedback Session
4:30 pm – 4:45 pm Forum Close and Next Steps
How to register to attend the AEPCC Forum 2023
Registration is essential and places are limited so please complete the details at this link to avoid missing out. Morning tea, lunch and afternoon tea will be provided.
Registration Costs
|
Senior, Mid, and Early-Career Researchers and Clinicians |
$30 |
|
Early Psychosis Lived Experience Community Members* |
no cost |
|
AEPCC Forum 2023 Bursary holders |
no cost |
* Early psychosis lived experience community members – those with a personal lived experience of early psychosis (including both first episode psychosis and at risk of psychosis), or a family member or carer of someone with early psychosis.
AEPCC Forum 2023 Bursary Applications
CLOSING at 5:00 pm AEST, Wednesday 1 March 2023
AEPCC is pleased of offer a number of bursaries to support the early psychosis lived experience community and early career researchers and clinicians to attend our Forum.
Please complete the AEPCC Forum 2023 Bursary Application Form if you would like to be considered for a bursary. Any questions can be sent to [email protected].
Please note the following important information:
-
- AEPCC Forum 2023 bursaries will cover attendees who do not live in Melbourne and must be used to cover travel and accommodation expenses. For example, 1 night accommodation and an economy return airfare to and from Melbourne or regional travel within Victoria.
-
- AEPCC will work with bursary awardees to determine the total amount of the bursary, based on location and other relevant factors. In some circumstances AEPCC may directly pay these costs on behalf of the bursary awardee.
-
- Tax invoice receipts must be provided for reimbursement to be provided. The number of bursaries available is limited and applicants must complete the form by the closing date to be considered.
About Clinical Trial Networks (CTNs)
In Australia, clinical trial networks have been successful in securing funding for important trials that have changed the course of many lives across a range of areas in health and medicine. CTNs are most successful when they have researchers, clinicians and those with a lived experience of the disorder working together to identify priorities, design real world trials and then allow the facilitation of more rapid translation of trial results into practice. This is what we are building with AEPCC and we are one of the first CTNs in the mental health sector.
You can find out more about CTNs at the ACTA website here.
